China Pharma Holdings (CPHI) Q4 2024 Annual Earnings
CPHI·Reported May 14, 2025·Before market open
China Pharma Holdings reported Q4 2024 revenue of $1.1M. Diluted EPS came in at $-0.24.
Revenue
$1.1M
Diluted EPS
$-0.24
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about China Pharma Holdings's Q4 2024 earnings report.
China Pharma Holdings (CPHI) reported Q4 2024 earnings on May 14, 2025 before market open.
China Pharma Holdings reported revenue of $1.1M and diluted EPS of $-0.24 for Q4 2024.
You can read the 10-K periodic report (0001213900-25-026280) directly on SEC EDGAR. The filing index links above go to sec.gov.